Blanco, C, Compton, WM, Saha, TD, Goldstein, BI, Ruan, WJ, Huang, B, et al. Epidemiology of DSM-5 bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions – Ill. J Psychiatr Res
2017; 84: 310–7.
Cassidy, F, Ahearn, EP, Carroll, BJ. Substance abuse in bipolar disorder. Bipolar Disord
2001; 3: 181–8.
Lasser, K, Boyd, JW, Woolhandler, S, Himmelstein, DU, Mccormick, D, Bor, DH. Smoking and mental illness: a population-based prevalence study. JAMA
2000; 284: 2606–10.
Jones, L, Metcalf, A, Gordon-Smith, K, Forty, L, Perry, A, Lloyd, J, et al. Gambling problems in bipolar disorder in the UK: prevalence and distribution. Br J Psychiatry
2015; 207: 328–33.
Salloum, IM, Cornelius, JR, Mezzich, JE, Kirisci, L. Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation. Bipolar Disord
2002; 4: 418–21.
Dalton, EJ, Cate-Carter, TD, Mundo, E, Parikh, SV, Kennedy, JL. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord
2003; 5: 58–61.
National Institute for Health and Care Excellence. Coexisting Severe Mental Illness and Substance Misuse: Community Health and Social Care Services.
Strakowski, SM, DelBello, MP, Fleck, DE, Arndt, S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry
2000; 48: 477–85.
Bizzarri, JV, Rucci, P, Sbrana, A, Gonnelli, C, Massei, GJ, Ravani, L, et al. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders. Addict Behav
2007; 32: 384–91.
Merikangas, KR, Herrell, R, Swendsen, J, Rossler, W, Ajdacic-Gross, V, Angst, J. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study. Arch Gen Psychiatry
2008; 65: 47–52.
Yip, SW, Doherty, J, Wakeley, J, Saunders, K, Tzagarakis, C, de Wit, H, et al. Reduced subjective response to acute ethanol administration among young men with a broad bipolar phenotype. Neuropsychopharmacology
2012; 37: 1808–15.
Nutt, DJ, Lingford-Hughes, A, Erritzoe, D, Stokes, PR. The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci
2015; 16: 305–12.
Nikolaus, S, Antke, C, Beu, M, Muller, HW. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders–results from in vivo imaging studies. Rev Neurosci
2010; 21: 119–39.
National Institute for Health and Care Excellence. Coexisting Severe Mental Illness (Psychosis) and Substance Misuse: Assessment and Management in Healthcare Settings (Clinical Guideline CG120).
Lingford-Hughes, AR, Welch, S, Peters, L, Nutt, DJ. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol
2012; 26: 899–952.
Dorus, W, Ostrow, DG, Anton, R, Cushman, P, Collins, JF, Schaefer, M, et al. Lithium treatment of depressed and nondepressed alcoholics. JAMA
1989; 262: 1646–52.
Salloum, IM, Cornelius, JR, Daley, DC, Kirisci, L, Himmelhoch, JM, Thase, ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry
2005; 62: 37–45.
Kemp, DE, Gao, K, Ganocy, SJ, Elhaj, O, Bilali, SR, Conroy, C, et al. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry
2009; 70: 113–21.
Brown, ES, Sunderajan, P, Hu, LT, Sowell, SM, Carmody, TJ. A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence. Neuropsychopharmacology
2012; 37: 2347–54.
Hollander, E, Pallanti, S, Allen, A, Sood, E, Baldini Rossi, N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Am J Psychiatry
2005; 162: 137–45.
Brown, ES, Davila, D, Nakamura, A, Carmody, TJ, Rush, AJ, Lo, A, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence. Alcohol Clin Exp Res
2014; 38: 2113–8.
Stedman, M, Pettinati, HM, Brown, ES, Kotz, M, Calabrese, JR, Raines, S. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcohol Clin Exp Res
2010; 34: 1822–31.
Tolliver, BK, Desantis, SM, Brown, DG, Prisciandaro, JJ, Brady, KT. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord
2012; 14: 54–63.
Brown, ES, Carmody, TJ, Schmitz, JM, Caetano, R, Adinoff, B, Swann, AC, et al. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res
2009; 33: 1863–9.